ClinicalTrials.gg
RecruitingNCT07554729SURVIVE 2Updated Apr 28, 2026

AN EXTENDED COHORT STUDY TO INVESTIGATE SUICIDAL BEHAVIOR IN SPAIN (THE SURVIVE 2 STUDY)

An observational study in Suicidal Behaviors, sponsored by Parc de Salut Mar. Recruiting at 2 sites in Spain. Open to participants aged 12 Years and older. Per ClinicalTrials.gov, last updated 2026-04-28.

Sponsored by Parc de Salut Mar · Observational

From the registry’s dates

  • Started Sep 2024; still recruiting 2 years 2 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
3,600
Ages
12 Years and older
Sex
All
01

Study summary

The goal of this observational study is to learn more about people who come to emergency departments in Spain after a suicide attempt and to find ways to prevent another attempt. The main questions are whether some personal, social, biological, and clinical factors are linked to a higher risk of trying again, and whether different follow-up strategies can help lower this risk over time.

Researchers will follow a total of about 3,600 people who attempted suicide: around 1,800 who were already recruited in a previous study and about 1,800 new participants who will be added in this project, in several hospitals across Spain.

Some participants may also be invited to give blood samples, answer online questionnaires, or use smartphone-based tools to understand better changes in mood and suicidal thoughts in daily life. A subset of participants may be invited to join separate clinical trials that test different follow-up programs to prevent another suicide attempt; these trials will be registered and described in their own study records.

Read the detailed description

BACKGROUND: Suicide is the leading preventable cause of death in the world. In Spain, the data show a growing trend in recent years, indicating the need to implement evidence-based prevention strategies. OBJECTIVES: The main objective of this study is to continue monitoring a previously established cohort of 1,800 suicide attempts and extend it to include 3,600 cases. The secondary objectives are: 1) to identify risk factors (1a: socioeconomic, psychological, and clinical, 1b: biological, and 1c: genetic) that can predict a repeat attempt, 2) to study suicidal behavior in the pandemic and post-pandemic times, 3) to identify phenotypes related to suicidal ideation and behavior using momentary ecological assessment and 4) to determine the efficacy of secondary prevention programs for suicidal behavior compared with treatment as usual (TaU). METHOD: Multi-center-coordinated cohort study with five nested clinical controlled trials. The participants will be recruited in nine centers distributed in the Spanish territory. The primary variable will be the time to repeat the attempt.

SUB-PROJECT 1: a) long-term follow-up study (5 years) of a cohort of suicide attempts (total n = 3600 cases), b) study of biological and c) genetic markers associated with a suicide attempt. SUB-PROJECT 2: will study suicidal ideation and behavior phenotypes using momentary ecological assessment and experience sampling. SUB-PROJECT 3: will evaluate the efficacy of different secondary prevention programs compared to TaU.

02

Conditions studied

  • Suicidal Behaviors

Browse trials for

Keywords

  • suicide
  • cohort study
03

In context

Suicide

607 studies on the registry are indexed under Suicide; 162 are open to participants now.

This study's planned enrollment of 3,600 is above the median of 150 across 98 observational studies indexed under Suicide.

Browse Suicide studies →

Lead sponsor

Parc de Salut Mar is the lead sponsor of 182 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Individuals (adolescents and adults) who present to the emergency departments of participating hospitals in Spain after a suicide attempt. The study will follow approximately 3,600 participants (about 1,800 already enrolled in a previous cohort and about 1,800 newly recruited) for up to 3 years to examine suicidal behavior and related risk and protective factors

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals (above 12 years old) who present to participating Spanish hospital emergency departments after a suicide attempt, as defined by self-injurious behavior with at least some intent to die.
  • Able to understand the study procedures and provide (or assent with parental/guardian consent for minors, according to local regulations)
  • Sufficient proficiency in Spanish to complete study assessments

Exclusion criteria

Exclusion Criteria:

  • Suicide attempts clearly judged as accidental or without suicidal intent
  • Severe cognitive impairment, intellectual disability, or neurological condition that, in the opinion of the clinical team, prevents valid assessment or
  • Acute medical instability that makes participation in research procedures unsafe.
  • Any condition or circumstance that, in the opinion of investigators, would seriously interfere with participation or follow-up in the cohort.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
3,600 participants (estimated)
Patient registry
No

Groups and cohorts

  • Suicide attempt cohort

    Adults and adolescents who present to participating Spanish hospitals after a suicide attempt and are enrolled in the SURVIVE cohort. This group includes about 1,800 participants from a previous study and about 1,800 newly recruited participants, all followed for up to 3 years.

06

What researchers measure

Primary outcomes

  1. Columbia Suicide Severity Rating Scale (C-SSRS)

    The Columbia-Suicide Severity Rating Scale (C-SSRS) is a brief, structured interview that uses simple questions about suicidal thoughts and behaviors to identify whether someone is at risk for suicide and how severe and urgent that risk is.

    Time frame: 1 year

Secondary outcomes

  1. Patient Health Questionnaire (PHQ-9)

    Nine-item self-report questionnaire that measures the severity of depressive symptoms over the past 2 weeks; total score ranges from 0 to 27, with higher scores indicating more severe depression.

    Time frame: 1 year

  2. Generalized Anxiety Disorder (GAD-7)

    Brief Description Seven-item self-report questionnaire that assesses symptoms of generalized anxiety during the past 2 weeks; total score ranges from 0 to 21, with higher scores indicating more severe anxiety.

    Time frame: 1 year

  3. McLean Screening Instrument for BPD (MSI-BPD)

    Self-report questionnaire that screens for symptoms of borderline personality disorder; total score reflects the severity of borderline traits.

    Time frame: 1 year

  4. Bruha Life Events

    Checklist of major stressful life events; higher counts indicate greater exposure to recent stressors.

    Time frame: 1 year

  5. Childhood Trauma Questionnaire (CTQ-SF)

    Twenty-eight-item self-report measure that assesses history of childhood maltreatment across five domains (emotional, physical and sexual abuse, and emotional and physical neglect); higher subscale and total scores indicate more severe childhood trauma.

    Time frame: baseline

  6. Insomnia Severity Index (ISI)

    Five-item self-report scale that measures insomnia symptoms and their impact; total score indicates insomnia severity

    Time frame: 1 year

  7. Alcohol Use (AUDIT-C)

    Three-item self-report questionnaire that screens for hazardous alcohol consumption; higher scores indicate higher risk drinking

    Time frame: 1 year

  8. Heaviness of Smoking Index (HSI)

    Two-item index derived from cigarettes per day and time to first cigarette; higher scores indicate greater nicotine dependence

    Time frame: 1 year

  9. Drug Abuse Screening Test (DAST)

    Self-report screening tool for problematic use of non-alcohol drugs; total score reflects severity of drug-related problems

    Time frame: 1 year

  10. Difficulties in Emotion Regulation Scale (DERS-18)

    Eighteen-item self-report measure of problems in emotion regulation across several domains; higher scores reflect greater difficulties regulating emotions.

    Time frame: 1 year

  11. Barratt Impulsiveness Scale (BIS-11)

    Self-report questionnaire with 30 items that evaluates different facets of impulsivity (attentional, motor and non-planning); higher total scores indicate greater impulsive traits.

    Time frame: 1 year

  12. Health-related Quality of Life (EuroQol-5D)

    Standardized questionnaire that assesses health-related quality of life across five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression); higher index values reflect better perceived health.

    Time frame: 1 year

  13. UCLA-3 Item Loneliness Scale

    Three-item self-report scale that screens for perceived loneliness and social isolation; higher scores indicate greater feelings of loneliness

    Time frame: 1 year

  14. Reflective Functioning Questionnaire - RFQ-8

    Eight-item self-report questionnaire that assesses difficulties in understanding one's own and others' mental states; scores reflect problems in reflective functioning/mentalizing.

    Time frame: 1 year

  15. Bulimic Investigatory Test, Edinburgh - BITE

    Self-report questionnaire that evaluates symptoms and severity of bulimic eating behaviors; higher scores indicate more severe bulimic pathology

    Time frame: 1 year

  16. Feelings of Emptiness (CSV)

    Self-report questionnaire that measures the frequency and intensity of chronic feelings of emptiness; higher scores indicate more severe feelings of emptiness, often associated with borderline and suicidal presentations.

    Time frame: 1 year

  17. Lubben Social Network Scale

    Brief questionnaire that assesses the size and frequency of supportive contacts with family and friends; lower scores indicate higher risk of social isolation

    Time frame: 1 year

  18. Sociodemographic and Clinical Characteristics (Ad-Hoc Questionnaire)

    Study-specific questionnaire developed by the research team to collect sociodemographic and basic clinical information (for example age, sex, education, employment, living situation, psychiatric history, and treatment). Data will be used to describe the sample and as covariates in analyses

    Time frame: Baseline

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared because the dataset includes highly sensitive information on suicidal behavior collected in a limited number of centers, which increases the risk of re-identification even after de-identification. Data sharing is therefore restricted to protect participant privacy and comply with ethical and regulatory requirements.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07554729
Lead sponsor
Parc de Salut Mar
Responsible party
Víctor Pérez (Doctor, Parc de Salut Mar) — Principal investigator
First posted
Apr 28, 2026
Start date
Sep 1, 2024
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Apr 28, 2026

Study contacts

Victor Perez-Sola, Dr
Contact
vperez@psmar.cat
+34 933160623
Matilde Elices, Dr
Contact
melices@researchmar.net
+34 933160623

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion